Business Context and Reporting Period
Company: Mustang Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 11, 2023
Event: Termination of a Material Definitive Agreement (Item 1.02).
Key Financial Metrics
This filing reports a specific transaction rather than periodic financial performance. Key figures include:
- Payoff Amount: $30.7 million (comprising principal, interest, and applicable final payment).
- Original Loan Facility: Up to $75.0 million in aggregate principal under the Runway Loan Agreement.
- Debt Status: The Runway Loan Agreement has been terminated.
The filing text does not provide clear values for revenue, profit, cash flow, margins, or overall liquidity beyond the specific payoff transaction.
Material Changes
On April 11, 2023, Mustang Bio, Inc. terminated the Loan and Security Agreement with Runway Growth Finance Corp. (Runway), originally dated March 4, 2022, and amended on December 7, 2022. The termination was executed upon the Company's payment of the $30.7 million payoff amount.
Outlook, Risks, and Contingencies
Remaining Obligations: Although the loan agreement is terminated, the Company remains bound by certain indemnification obligations under Section 12.3 of the Runway Loan Agreement.
Unusual Items: The payoff was executed pursuant to a payoff letter with Runway. No forward-looking guidance or management commentary regarding future operations is included in this specific filing.
Investor Verification Checklist
- Verify the impact of the $30.7 million cash outflow on the Company's current cash position and liquidity.
- Review the specific terms of the remaining indemnification obligations under Section 12.3 of the terminated agreement.
- Confirm whether the termination of this facility affects any other outstanding debt or financing arrangements.